PDS Biotechnology Corporation

NasdaqCM:PDSB Stock Report

Mkt Cap: US$163.3m

PDS Biotechnology Management

Management criteria checks 3/4

PDS Biotechnology's CEO is Frank Bedu-Addo, appointed in Mar 2019, has a tenure of 4.75 years. total yearly compensation is $2.30M, comprised of 23.5% salary and 76.5% bonuses, including company stock and options. directly owns 2.22% of the company’s shares, worth $3.63M. The average tenure of the management team and the board of directors is 2.9 years and 4.8 years respectively.

Key information

Frank Bedu-Addo

Chief executive officer

US$2.3m

Total compensation

CEO salary percentage23.5%
CEO tenure4.8yrs
CEO ownership2.2%
Management average tenure2.9yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

PDS Biotech jumps 13% as FDA clears further development of lead asset

Oct 03

PDS Biotechnology files for $150 mixed shelf offering

Aug 24

PDS Biotech spikes as panel backs continuation of cancer trial for lead asset

Aug 04

PDS Biotechnology (NASDAQ:PDSB) Is In A Strong Position To Grow Its Business

Jul 08
PDS Biotechnology (NASDAQ:PDSB) Is In A Strong Position To Grow Its Business

PDS Biotechnology: Speculative Biotech Worth Buying After Latest Data

May 27

PDS Biotechnology: Versamune Platform Targeting HPV-Associated Cancers

Feb 22

PDS Biotech: Looking Attractive Despite 52-Week High Price

Sep 19

PDS Biotech under pressure after pricing equity offering at $8.50

Jun 15

PDS Biotech announces preliminary efficacy readout from phase 2 combo trial of PDS0101

Feb 03

PDS Biotechnology gives new CFO ~202K stock grant

Jan 06

PDS Biotech launches mid-stage PDS0101 combo trial in head & neck cancer

Nov 10

CEO Compensation Analysis

How has Frank Bedu-Addo's remuneration changed compared to PDS Biotechnology's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2023n/an/a

-US$51m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$42m

Dec 31 2022US$2mUS$540k

-US$41m

Sep 30 2022n/an/a

-US$28m

Jun 30 2022n/an/a

-US$28m

Mar 31 2022n/an/a

-US$22m

Dec 31 2021US$7mUS$475k

-US$17m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$12m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$815kUS$450k

-US$15m

Sep 30 2020n/an/a

-US$15m

Jun 30 2020n/an/a

-US$17m

Mar 31 2020n/an/a

-US$18m

Dec 31 2019US$3mUS$356k

-US$7m

Compensation vs Market: Frank's total compensation ($USD2.30M) is above average for companies of similar size in the US market ($USD1.62M).

Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.


CEO

Frank Bedu-Addo (58 yo)

4.8yrs

Tenure

US$2,302,548

Compensation

Dr. Frank K. Bedu-Addo, Ph D., served as Interim Principal Financial Officer for PDS Biotechnology Corporation since September 30, 2021 until October 2021. He serves as Chief Executive Officer of PDS Biote...


Leadership Team

NamePositionTenureCompensationOwnership
Frank Bedu-Addo
President4.8yrsUS$2.30m2.22%
$ 3.6m
Matthew Hill
CFO, Principal Financial & Accounting Officer2.2yrsUS$504.09k0.013%
$ 21.4k
Lauren Wood
Chief Medical Officer4.8yrsUS$1.01m0%
$ 0
Joe Dervan
VP of Research & Development2.9yrsno datano data
Gregory Conn
Chief Scientific Officer4.8yrsUS$1.32m0.38%
$ 617.8k
Deanne Randolph
Head of Investor Relationsno datano datano data
Spencer Brown
Senior VP & General Counsel1.5yrsno data0%
$ 0
Sanjay Zaveri
Senior Vice President of Business Development1.6yrsno datano data
Janetta Trochimiuk
Controllerno datano datano data

2.9yrs

Average Tenure

59yo

Average Age

Experienced Management: PDSB's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frank Bedu-Addo
President4.8yrsUS$2.30m2.22%
$ 3.6m
Gregory Freitag
Independent Director4.8yrsUS$89.82k0.15%
$ 242.3k
Richard Sykes
Independent Director4.8yrsUS$78.82k1.43%
$ 2.3m
Stephen Glover
Independent Chairman4.7yrsUS$120.32k0.21%
$ 334.9k
Jerold Woodward
Member of Scientific Advisory Boardno datano datano data
Kamil Ali-Jackson
Independent Director3.8yrsUS$90.82k0.038%
$ 61.8k
Mark Einstein
Member of Scientific Advisory Boardno datano datano data
Darron Brown
Member of Scientific Advisory Boardno datano datano data
Leaf Huang
Member of Scientific Advisory Boardno datano datano data
Samir Khleif
Member of Scientific Advisory Boardno datano datano data
Lisa Rohan
Member of Scientific Advisory Boardno datano datano data
Neil Gross
Member of Scientific Advisory Boardno datano datano data

4.8yrs

Average Tenure

62yo

Average Age

Experienced Board: PDSB's board of directors are considered experienced (4.8 years average tenure).